About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- piroxicam
- Procedure number
- PSUSA/00002438/202304
- Regulatory outcome
- Variation
Documents
Piroxicam : List of nationally authorised medicinal products - PSUSA/00002438/202304
English (EN) (260.52 KB - PDF)
Piroxicam : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002438/202304
English (EN) (78.61 KB - PDF)
български (BG) (77.17 KB - PDF)
español (ES) (78.73 KB - PDF)
čeština (CS) (81.53 KB - PDF)
dansk (DA) (81.29 KB - PDF)
Deutsch (DE) (87.23 KB - PDF)
eesti keel (ET) (77.33 KB - PDF)
ελληνικά (EL) (74.37 KB - PDF)
français (FR) (80.69 KB - PDF)
hrvatski (HR) (77.17 KB - PDF)
íslenska (IS) (81.11 KB - PDF)
italiano (IT) (117.4 KB - PDF)
latviešu valoda (LV) (93.36 KB - PDF)
lietuvių kalba (LT) (90.91 KB - PDF)
magyar (HU) (81.18 KB - PDF)
Malti (MT) (106.23 KB - PDF)
Nederlands (NL) (83.25 KB - PDF)
norsk (NO) (78.49 KB - PDF)
polski (PL) (82.13 KB - PDF)
português (PT) (78.57 KB - PDF)
română (RO) (77.25 KB - PDF)
slovenčina (SK) (83.18 KB - PDF)
slovenščina (SL) (77.12 KB - PDF)
Suomi (FI) (73.64 KB - PDF)
svenska (SV) (79.11 KB - PDF)